Orbital infection and idiopathic inflammation

Orbital Cellulitis vs. Preseptal Cellulitis

The orbital septum is a thin, fibrous sheet originating from the periosteum of the orbital rims (arcus marginale) and fusing with the retractor aponeurosis in the eyelids. It forms an essential physiological and anatomical barrier preventing superficial periorbital cutaneous infections from spreading into the deeper orbital space.

Clinical Differentiation

Pathophysiology & Microbiology of Orbital Cellulitis

• Pathogenesis: Orbital cellulitis often follows contiguous spread from adjacent sinus infection, particularly ethmoid sinusitis, especially in children; the distribution varies with age and setting. Bacteria traverse the thin, perforated lamina papyracea directly or travel along the valveless orbital ophthalmic venous plexuses and Breschet's diploic canals. Secondary causes include orbital trauma, retained wooden or organic foreign bodies, dacryocystitis, dental root abscesses, and septic bacteremic embolization.
• Microbiology:
  • Streptococcus pneumoniae (most common in community-acquired sinus sources)
  • Staphylococcus aureus (including methicillin-resistant S. aureus [MRSA], particularly common after cutaneous trauma or surgical disruption)
  • Streptococcus pyogenes (Group A Strep)
  • Haemophilus influenzae type b (markedly reduced since conjugate vaccination, but still seen in unimmunized pediatric cohorts)
  • Polymicrobial Anaerobes (Bacteroides, Peptostreptococcus, Fusobacterium): Common in older children and adults with chronic dentoalveolar or multisinus disease.

Complications: Subperiosteal Abscess & Cavernous Sinus Thrombosis

1. Subperiosteal Abscess (SPA): A localized accumulation of purulent material between the periorbita (orbital periosteum) and the bony orbital wall, most frequently along the medial wall secondary to ethmoiditis. Periorbita acts as a tough mechanical barrier detaching from the bone.
   • Surgical Drainage Indications for SPA:
     • A large or non-medial abscess, concerning progression or inadequate source control; size, location and the overall clinical state inform the decision rather than one universal linear cutoff
     • Evidence of optic nerve compromise (decreased vision, RAPD, visual field loss)
     • Intracranial extension or co-existing frontal sinus abscess
     • Lack of clinical improvement or progressive deterioration within 24 to 48 hours of parenteral intravenous antibiotic therapy.
2. Cavernous Sinus Thrombosis (CST): Septic retrograde thrombosis extending via the superior and inferior ophthalmic veins into the cavernous sinus.
   • Cardinal Signs: Bilateralization of orbital signs (contralateral proptosis and chemosis), abducens (CN VI) nerve palsy as the earliest sign (due to its free-floating course in the center of the sinus adjacent to the carotid), rapid development of complete internal and external ophthalmoplegia (CN III, IV, VI), severe hypoesthesia in $V_1/V_2$ distributions, high-spiking septic fever, and altered consciousness. Carries high mortality.

Idiopathic Orbital Inflammatory Disease (IOID)

Idiopathic Orbital Inflammatory Disease (IOID), historically designated orbital pseudotumour, is a benign, non-granulomatous, non-infectious, fibro-inflammatory space-occupying lesion of the orbit characterized by a polymorphous lymphoplasmacytic infiltrate without identifiable local or systemic etiology.

Clinical Presentation & Subtypes

IOID characteristically presents in middle-aged adults with an abrupt, explosive onset of severe, deep orbital pain, marked periorbital oedema, proptosis, ptosis, and diplopia. The disease is typically unilateral, although bilateral presentation can occur (more common in pediatric patients, which mandates an exhaustive workup for systemic vasculitis, sarcoidosis, or lymphoma).

Anatomical subtypes include:

• Orbital Myositis: Inflammation localized to one or more extraocular muscles (presenting with severe pain exacerbated by specific gaze movements).
• Dacryoadenitis: Inflammation localized to the lacrimal gland (producing a classic S-shaped ptosis and tender superolateral orbital rim mass).
• Anterior Orbital Inflammation: Involving the sclera (scleritis), Tenon's capsule, and anterior fat.
• Apical Orbital Inflammation / Tolosa-Hunt Syndrome: Inflammatory infiltration of the orbital apex and superior orbital fissure / cavernous sinus, producing painful ophthalmoplegia and sensory loss along $V_1$.

CT/MRI patterns and their limitations

Neuroimaging provides the essential radiologic distinction between IOID (orbital myositis) and Thyroid Eye Disease:

• IOID (Myositis): Diffuse inflammatory enlargement involving BOTH the extraocular muscle belly AND its anterior tendinous insertion onto the sclera. Associated with periorbital stranding, ragged muscle margins, and diffuse infiltration of the adjacent orbital fat.
• Thyroid Eye Disease: Spindle-shaped, fusiform enlargement of the muscle belly with crisp sparing of the anterior tendon.

Management and the limits of steroid response

• Systemic corticosteroids: After infection and relevant neoplasia have been assessed, selected IOI can be treated with systemic corticosteroids under specialist supervision. Response can be rapid, but is neither universal nor diagnostic; lymphoma can also improve temporarily. Taper and steroid-sparing treatment depend on phenotype, relapse and adverse effects.
• Orbital Biopsy: Indicated if there is an atypical clinical presentation, palpable anterior mass, lack of immediate response to corticosteroids, rapid relapse during steroid tapering, or bony erosion on imaging, to exclude orbital lymphoma, IgG4-related ophthalmic disease, sarcoidosis, or Granulomatosis with Polyangiitis (GPA).

Comprehensive Diagnostic Differentiation: TED vs IOID vs Orbital Cellulitis

Orbital Infection and Inflammation Safety

New RAPD, visual loss, severe restriction, proptosis or neurological signs require urgent orbital/ENT assessment and imaging. Subperiosteal-abscess drainage depends on vision, age, site/size, intracranial risk, progression and response, rather than an absolute age-nine rule. Use IV antibiotics selected by likely source, resistance and allergy and coordinate sinus source control. Chemosis alone does not establish orbital infection. IOI is a diagnosis of exclusion; response to steroids is not proof, since lymphoma can transiently improve. Atypical or recurrent lesions may require tissue before steroids where feasible, with infection and malignancy assessed first.